Th\u00e0nh ph\u1ea7n<\/span><\/h3>\nThu\u1ed1c Gliptinestad 25<\/strong> c\u00f3 ch\u1ee9a th\u00e0nh ph\u1ea7n:<\/span><\/p>\n\n- Sitagliptin 25mg<\/span><\/li>\n
- T\u00e1 d\u01b0\u1ee3c v\u1eeba \u0111\u1ee7 1 vi\u00ean<\/span><\/li>\n<\/ul>\n
D\u1ea1ng b\u00e0o ch\u1ebf: Vi\u00ean n\u00e9n bao phim<\/span><\/p>\nTr\u00ecnh b\u00e0y<\/span><\/h3>\nS\u0110K: \u0110ang c\u1eadp nh\u1eadt<\/span><\/p>\nQuy c\u00e1ch \u0111\u00f3ng g\u00f3i: H\u1ed9p 28 vi\u00ean<\/span><\/p>\nXu\u1ea5t x\u1ee9: Vi\u1ec7t Nam<\/span><\/p>\nT\u00e1c d\u1ee5ng c\u1ee7a thu\u1ed1c Gliptinestad 25<\/span><\/h2>\nC\u01a1 ch\u1ebf t\u00e1c d\u1ee5ng<\/span><\/h3>\nSitagliptin<\/strong>:<\/span><\/p>\n\n- \u1ee8c ch\u1ebf dipeptidyl peptidase-4 (DPP-4) – enzym l\u00e0m b\u1ea5t ho\u1ea1t c\u00e1c hormone k\u00edch th\u00edch ti\u1ebft Insulin.<\/span><\/li>\n
- T\u0103ng n\u1ed3ng \u0111\u1ed9 GIP v\u00e0 GLP-1 – k\u00edch th\u00edch s\u1ea3n sinh Insulin v\u00e0 gi\u1ea3m s\u1ea3n xu\u1ea5t glucose.<\/span><\/li>\n
- Hi\u1ec7u qu\u1ea3 trong vi\u1ec7c h\u1ea1 glucose huy\u1ebft l\u00fac \u0111\u00f3i v\u00e0 sau \u0103n.<\/span><\/li>\n
- \u00cdt g\u00e2y h\u1ea1 \u0111\u01b0\u1eddng huy\u1ebft qu\u00e1 m\u1ee9c v\u00e0 kh\u00f4ng l\u00e0m \u1ea3nh h\u01b0\u1edfng kh\u1ed1i l\u01b0\u1ee3ng c\u01a1 th\u1ec3.<\/span><\/li>\n<\/ul>\n
\u0110\u1eb7c \u0111i\u1ec3m d\u01b0\u1ee3c \u0111\u1ed9ng h\u1ecdc\u00a0<\/span><\/h3>\nH\u1ea5p thu:<\/span><\/p>\n\n- Sitagliptin \u0111\u01b0\u1ee3c h\u1ea5p thu nhanh qua ti\u00eau h\u00f3a.<\/span><\/li>\n
- Kh\u1ea3 d\u1ee5ng sinh h\u1ecdc hay t\u1ef7 l\u1ec7 Sitagliptin h\u1ea5p thu v\u00e0o c\u01a1 th\u1ec3 \u0111\u1ea1t 87%.<\/span><\/li>\n
- \u0110\u1ec9nh n\u1ed3ng \u0111\u1ed9 thu\u1ed1c trong m\u00e1u \u0111\u1ea1t sau 3h u\u1ed1ng.<\/span><\/li>\n
- Qu\u00e1 tr\u00ecnh h\u1ea5p thu kh\u00f4ng b\u1ecb \u1ea3nh h\u01b0\u1edfng b\u1edfi vi\u1ec7c \u0103n u\u1ed1ng.<\/span><\/li>\n
- B\u1eaft \u0111\u1ea7u c\u00f3 hi\u1ec7u qu\u1ea3 sau 1h u\u1ed1ng.<\/span><\/li>\n
- Kh\u1ea3 n\u0103ng \u1ee9c ch\u1ebf DPP-4 \u0111\u1ea1t 80% v\u00e0 k\u00e9o d\u00e0i 12-24 gi\u1edd.<\/span><\/li>\n<\/ul>\n
Ph\u00e2n b\u1ed1:<\/span><\/p>\n\n- Sitagliptin ph\u00e2n b\u1ed1 r\u1ed9ng kh\u1eafp c\u01a1 th\u1ec3 v\u1edbi th\u1ec3 t\u00edch ph\u00e2n b\u1ed1 kho\u1ea3ng 198 l\u00edt.<\/span><\/li>\n
- 38% c\u1ee7a Sitagliptin k\u1ebft h\u1ee3p v\u1edbi protein trong huy\u1ebft t\u01b0\u01a1ng.<\/span><\/li>\n<\/ul>\n
Chuy\u1ec3n h\u00f3a:<\/span><\/p>\n\n- Sitagliptin \u0111\u01b0\u1ee3c chuy\u1ec3n h\u00f3a ch\u1ee7 y\u1ebfu b\u1edfi h\u1ec7 th\u1ed1ng cytochrom P450 (CYP), bao g\u1ed3m isoenzym CYP3A4 v\u00e0 CYP2C8.<\/span><\/li>\n
- Chuy\u1ec3n h\u00f3a s\u1ea3n xu\u1ea5t c\u00e1c ch\u1ea5t chuy\u1ec3n h\u00f3a kh\u00f4ng c\u00f3 ho\u1ea1t t\u00ednh.<\/span><\/li>\n<\/ul>\n
Th\u1ea3i tr\u1eeb:<\/span><\/p>\n\n- 87% gi\u1eef nguy\u00ean \u1edf d\u1ea1ng kh\u00f4ng \u0111\u1ed5i qua n\u01b0\u1edbc ti\u1ec3u.<\/span><\/li>\n
- Ph\u1ea7n c\u00f2n l\u1ea1i (kho\u1ea3ng 13%) \u0111\u01b0\u1ee3c th\u1ea3i tr\u1eeb qua ph\u00e2n.<\/span><\/li>\n
- Sitagliptin \u0111\u01b0\u1ee3c b\u00e0i ti\u1ebft qua \u1ed1ng th\u1eadn theo ph\u01b0\u01a1ng th\u1ee9c v\u1eadn chuy\u1ec3n t\u00edch c\u1ef1c.<\/span><\/li>\n
- Th\u1eddi gian c\u1ea7n \u0111\u1ec3 m\u1ed9t n\u1eeda l\u01b0\u1ee3ng Sitagliptin \u0111\u01b0\u1ee3c th\u1ea3i lo\u1ea1i kh\u1ecfi c\u01a1 th\u1ec3 l\u00e0 12,4 gi\u1edd.<\/span><\/li>\n<\/ul>\n
Thu\u1ed1c Gliptinestad 25 Stella \u0111\u01b0\u1ee3c ch\u1ec9 \u0111\u1ecbnh trong b\u1ec7nh g\u00ec?<\/span><\/h2>\n\u0110i\u1ec1u ch\u1ec9nh \u0111\u01b0\u1eddng huy\u1ebft \u1edf ng\u01b0\u1eddi b\u1ec7nh \u0111\u00e1i th\u00e1o \u0111\u01b0\u1eddng t\u00fdp 2:<\/span><\/p>\nLi\u1ec7u ph\u00e1p \u0111\u01a1n \u0111\u1ed9c:<\/span><\/p>\n\n- \u00c1p d\u1ee5ng khi ch\u1ebf \u0111\u1ed9 \u0103n u\u1ed1ng & t\u1eadp luy\u1ec7n kh\u00f4ng hi\u1ec7u qu\u1ea3 ho\u1eb7c kh\u00f4ng th\u1ec3\/kh\u00f4ng dung n\u1ea1p metformin.<\/span><\/li>\n<\/ul>\n
Tr\u1ecb li\u1ec7u k\u00e9p:<\/span><\/p>\n\n- Metformin: S\u1eed d\u1ee5ng khi ch\u1ebf \u0111\u1ed9 \u0103n u\u1ed1ng, t\u1eadp luy\u1ec7n & Metformin \u0111\u01a1n \u0111\u1ed9c kh\u00f4ng hi\u1ec7u qu\u1ea3.<\/span><\/li>\n
- Sulphonylurea: D\u00f9ng khi ch\u1ebf \u0111\u1ed9 \u0103n u\u1ed1ng, t\u1eadp luy\u1ec7n & Sulfonylurea \u0111\u01a1n \u0111\u1ed9c (li\u1ec1u t\u1ed1i \u0111a) kh\u00f4ng hi\u1ec7u qu\u1ea3 v\u00e0 kh\u00f4ng th\u1ec3\/kh\u00f4ng dung n\u1ea1p metformin.<\/span><\/li>\n
- Ch\u1ea5t ch\u1ee7 v\u1eadn PPAR\u03b3 (thiazolidinedione): D\u00f9ng khi ph\u00f9 h\u1ee3p v\u00e0 ch\u1ebf \u0111\u1ed9 \u0103n u\u1ed1ng, t\u1eadp luy\u1ec7n & ch\u1ea5t ch\u1ee7 v\u1eadn PPAR\u03b3 \u0111\u01a1n \u0111\u1ed9c kh\u00f4ng hi\u1ec7u qu\u1ea3.<\/span><\/li>\n<\/ul>\n
Tr\u1ecb li\u1ec7u 3 thu\u1ed1c:<\/span><\/p>\n\n- Sulphonylurea & Metformin: D\u00f9ng khi 2 thu\u1ed1c n\u00e0y c\u00f9ng ch\u1ebf \u0111\u1ed9 \u0103n u\u1ed1ng & t\u1eadp luy\u1ec7n kh\u00f4ng hi\u1ec7u qu\u1ea3.<\/span><\/li>\n
- Ch\u1ea5t ch\u1ee7 v\u1eadn PPAR\u03b3 & Metformin: D\u00f9ng khi ph\u00f9 h\u1ee3p v\u00e0 2 thu\u1ed1c n\u00e0y c\u00f9ng ch\u1ebf \u0111\u1ed9 \u0103n u\u1ed1ng & t\u1eadp luy\u1ec7n kh\u00f4ng hi\u1ec7u qu\u1ea3.<\/span><\/li>\n<\/ul>\n
L\u1ef1a ch\u1ecdn k\u1ebft h\u1ee3p Sitagliptin v\u1edbi insulin (c\u00f9ng ho\u1eb7c kh\u00f4ng c\u00f9ng metformin) \u0111\u01b0\u1ee3c c\u00e2n nh\u1eafc khi ch\u1ebf \u0111\u1ed9 \u0103n u\u1ed1ng, t\u1eadp luy\u1ec7n & insulin (li\u1ec1u \u1ed5n \u0111\u1ecbnh) kh\u00f4ng \u0111\u1ee7 \u0111\u1ec3 ki\u1ec3m so\u00e1t l\u01b0\u1ee3ng \u0111\u01b0\u1eddng trong m\u00e1u.<\/span><\/p>\nLi\u1ec1u d\u00f9ng c\u1ee7a thu\u1ed1c Gliptinestad 25<\/span><\/h2>\nLi\u1ec1u d\u00f9ng<\/span><\/h3>\n\n\n\n| \u0110\u1ed1i t\u01b0\u1ee3ng<\/span><\/td>\n | Li\u1ec1u d\u00f9ng<\/span><\/td>\n<\/tr>\n\n| Ng\u01b0\u1eddi tr\u01b0\u1edfng th\u00e0nh<\/span><\/td>\n | 4 vi\u00ean\/l\u1ea7n\/ng\u00e0y<\/span><\/td>\n<\/tr>\n\n| K\u1ebft h\u1ee3p v\u1edbi Metformin v\u00e0\/ho\u1eb7c ch\u1ea5t ch\u1ee7 v\u1eadn PPAR\u03b3<\/span><\/td>\n | Duy tr\u00ec li\u1ec1u Metformin\/PPAR\u03b3 v\u00e0 d\u00f9ng \u0111\u1ed3ng th\u1eddi Gliptinestad<\/span><\/td>\n<\/tr>\n\n| K\u1ebft h\u1ee3p v\u1edbi Sulphonylurea ho\u1eb7c insulin<\/span><\/td>\n | Xem x\u00e9t gi\u1ea3m li\u1ec1u Sulphonylurea\/Insulin \u0111\u1ec3 gi\u1ea3m nguy c\u01a1 h\u1ea1 \u0111\u01b0\u1eddng huy\u1ebft<\/span><\/td>\n<\/tr>\n\n| Ng\u01b0\u1eddi cao tu\u1ed5i<\/span><\/td>\n | Kh\u00f4ng c\u1ea7n \u0111i\u1ec1u ch\u1ec9nh li\u1ec1u<\/span><\/td>\n<\/tr>\n\n| Tr\u1ebb em d\u01b0\u1edbi 17 tu\u1ed5i<\/span><\/td>\n | Kh\u00f4ng d\u00f9ng<\/span><\/td>\n<\/tr>\n\nSuy th\u1eadn<\/span><\/td>\n<\/tr>\n\n\n\n- GFR \u2265 60 \u0111\u1ebfn < 90 ml\/ph\u00fat<\/span><\/li>\n<\/ul>\n<\/td>\n
4 vi\u00ean\/l\u1ea7n\/ng\u00e0y<\/span><\/td>\n<\/tr>\n\n\n\n- GFR \u2265 45 \u0111\u1ebfn < 60 ml\/ph\u00fat<\/span><\/li>\n<\/ul>\n<\/td>\n
4 vi\u00ean\/l\u1ea7n\/ng\u00e0y<\/span><\/td>\n<\/tr>\n\n\n\n- GFR \u2265 30 \u0111\u1ebfn < 45 ml\/ph\u00fat<\/span><\/li>\n<\/ul>\n<\/td>\n
2 vi\u00ean\/l\u1ea7n\/ng\u00e0y<\/span><\/td>\n<\/tr>\n\n\n\n- GFR \u2265 15 \u0111\u1ebfn < 30 ml\/ph\u00fat ho\u1eb7c ESRD (GFR < 15 ml\/ph\u00fat)<\/span><\/li>\n<\/ul>\n<\/td>\n
| 1 vi\u00ean\/l\u1ea7n\/ng\u00e0y<\/span><\/p>\n D\u00f9ng m\u1ecdi l\u00fac, kh\u00f4ng b\u1ecb \u1ea3nh h\u01b0\u1edfng b\u1edfi th\u1eddi gian th\u1ea9m t\u00e1ch m\u00e1u.<\/span><\/td>\n<\/tr>\n\nSuy gan<\/span><\/td>\n<\/tr>\n\n\n\n- Nh\u1eb9 \u0111\u1ebfn v\u1eeba<\/span><\/li>\n<\/ul>\n<\/td>\n
Kh\u00f4ng c\u1ea7n \u0111i\u1ec1u ch\u1ec9nh li\u1ec1u<\/span><\/td>\n<\/tr>\n\n\n\n- N\u1eb7ng<\/span><\/li>\n<\/ul>\n<\/td>\n
Th\u1eadn tr\u1ecdng, ch\u01b0a c\u00f3 nghi\u00ean c\u1ee9u \u0111\u1ea7y \u0111\u1ee7<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\nC\u00e1ch d\u00f9ng<\/span><\/h3>\n\n- Gliptinestad 25 c\u00f3 th\u1ec3 u\u1ed1ng c\u00f9ng ho\u1eb7c kh\u00f4ng c\u00f9ng th\u1ee9c \u0103n.<\/span><\/li>\n<\/ul>\n
Kh\u00f4ng s\u1eed d\u1ee5ng thu\u1ed1c Gliptinestad 25 trong tr\u01b0\u1eddng h\u1ee3p n\u00e0o?<\/span><\/h2>\nD\u1ecb \u1ee9ng v\u1edbi Sitagliptin ho\u1eb7c b\u1ea5t k\u1ef3 th\u00e0nh ph\u1ea7n n\u00e0o c\u1ee7a thu\u1ed1c Gliptinestad 25 Stella.<\/strong><\/span><\/p>\n\u0110\u00e1i th\u00e1o \u0111\u01b0\u1eddng type 1.<\/span><\/p>\nNg\u01b0\u1eddi c\u00f3 nhi\u1ec5m toan ceton do ti\u1ec3u \u0111\u01b0\u1eddng.<\/span><\/p>\nVi\u00eam t\u1ee5y c\u1ea5p.<\/span><\/p>\nL\u01b0u \u00fd \u0111\u1eb7c bi\u1ec7t khi s\u1eed d\u1ee5ng thu\u1ed1c Gliptinestad 25<\/span><\/h2>\nTh\u1eadn tr\u1ecdng<\/span><\/h3>\n\n- H\u1ea1 \u0111\u01b0\u1eddng huy\u1ebft khi d\u00f9ng k\u1ebft h\u1ee3p v\u1edbi insulin ho\u1eb7c sulphonylurea (c\u00e2n nh\u1eafc gi\u1ea3m li\u1ec1u).<\/span><\/li>\n
- C\u1ea7n gi\u1ea3m li\u1ec1u Sitagliptin \u1edf b\u1ec7nh nh\u00e2n suy th\u1eadn (GFR < 45 ml\/ph\u00fat) ho\u1eb7c b\u1ec7nh th\u1eadn giai \u0111o\u1ea1n cu\u1ed1i (ESRD) \u0111ang th\u1ea9m t\u00e1ch m\u00e1u ho\u1eb7c th\u1ea9m ph\u00e2n ph\u00fac m\u1ea1c.<\/span><\/li>\n
- Ph\u1ea3n \u1ee9ng qu\u00e1 m\u1eabn (ng\u01b0ng d\u00f9ng thu\u1ed1c, \u0111\u00e1nh gi\u00e1 nguy\u00ean nh\u00e2n, thay th\u1ebf c\u00e1ch tr\u1ecb li\u1ec7u).<\/span><\/li>\n
- B\u1ec7nh da b\u1ecdng n\u01b0\u1edbc pemphigoid (d\u1eebng thu\u1ed1c).<\/span><\/li>\n<\/ul>\n
T\u00e1c d\u1ee5ng kh\u00f4ng mong mu\u1ed1n<\/span><\/h3>\nTh\u01b0\u1eddng g\u1eb7p<\/span><\/p>\n\n- Gi\u1ea3m \u0111\u01b0\u1eddng huy\u1ebft<\/span><\/li>\n
- Nh\u1ee9c \u0111\u1ea7u.<\/span><\/li>\n<\/ul>\n
\u00cdt g\u1eb7p<\/span><\/p>\n\n- Hoa m\u1eaft<\/span><\/li>\n
- B\u00ed \u0111\u1ea1i ti\u1ec7n<\/span><\/li>\n
- Ng\u1ee9a ng\u00e1y<\/span><\/li>\n<\/ul>\n
T\u01b0\u01a1ng t\u00e1c thu\u1ed1c<\/span><\/h3>\n\n\n\n| Thu\u1ed1c<\/span><\/td>\n | T\u01b0\u01a1ng t\u00e1c thu\u1ed1c<\/span><\/td>\n<\/tr>\n\nThu\u1ed1c t\u00e1c \u0111\u1ed9ng l\u00ean Sitagliptin<\/span><\/td>\n<\/tr>\n\n| Ch\u1ea5t \u1ee9c ch\u1ebf m\u1ea1nh CYP3A4<\/span><\/td>\n | C\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn d\u01b0\u1ee3c \u0111\u1ed9ng h\u1ecdc c\u1ee7a Sitagliptin \u1edf ng\u01b0\u1eddi b\u1ec7nh suy th\u1eadn n\u1eb7ng ho\u1eb7c b\u1ec7nh th\u1eadn giai \u0111o\u1ea1n cu\u1ed1i.<\/span><\/td>\n<\/tr>\n\n| Probencid<\/span><\/td>\n | \u1ee8c ch\u1ebf qu\u00e1 tr\u00ecnh v\u1eadn chuy\u1ec3n Sitagliptin qua h\u1ec7 OAT3, ch\u01b0a c\u00f3 \u1ea3nh h\u01b0\u1edfng quan tr\u1ecdng trong th\u1ef1c t\u1ebf l\u00e2m s\u00e0ng.<\/span><\/td>\n<\/tr>\n\nSitagliptin t\u00e1c \u0111\u1ed9ng l\u00ean c\u00e1c thu\u1ed1c kh\u00e1c<\/span><\/td>\n<\/tr>\n\n| Digoxin<\/span><\/td>\n | T\u0103ng n\u1ed3ng \u0111\u1ed9 Digoxin trong huy\u1ebft t\u01b0\u01a1ng. Kh\u00f4ng c\u1ea7n \u0111i\u1ec1u ch\u1ec9nh li\u1ec1u v\u1edbi Digoxin, nh\u01b0ng c\u1ea7n th\u1eadn tr\u1ecdng \u0111\u1ed1i v\u1edbi b\u1ec7nh nh\u00e2n c\u00f3 nguy c\u01a1 ng\u1ed9 \u0111\u1ed9c.<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\nL\u01b0u \u00fd khi s\u1eed d\u1ee5ng cho ph\u1ee5 n\u1eef mang thai v\u00e0 ph\u1ee5 n\u1eef cho con b\u00fa<\/span><\/h3>\nKh\u00f4ng s\u1eed d\u1ee5ng Gliptinestad 25.<\/span><\/p>\nQu\u00e1 li\u1ec1u v\u00e0 x\u1eed tr\u00ed<\/span><\/h3>\nTri\u1ec7u ch\u1ee9ng:<\/span><\/p>\n | | | | | | | | | | | | | | | | | | | | | | | | | |